| Efficacy and Safety of Qurevo Plus Ribavirin Based Therapy for Hepatitis C With or Without Cirrhosis in Haemodialysis Patients (NCT03067883) | Ain Shams University | 2016-11-09 |
| A Study of LY2951742 (Galcanezumab) in Japanese Participants With Episodic Migraine (NCT02959177) | Eli Lilly and Company | 2016-11-09 |
| A Study Evaluating Safety and Efficacy of Obinutuzumab, Polatuzumab Vedotin (Pola), and Atezolizumab (Atezo) in Participants With Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab, Atezo, and Pola in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (NCT02729896) | Hoffmann-La Roche | 2016-11-09 |
| Management of Mild Cognitive Impairment Patients With Extra Virgin Olive Oil - MICOIL (NCT03362996) | Greek Alzheimer's Association and Related Disorders | 2016-11-09 |
| A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy (NCT02607891) | Jazz Pharmaceuticals | 2016-11-09 |
| Open-Label Extension and Safety Study of Talazoparib (NCT02921919) | Pfizer | 2016-11-08 |
| The Probiotic Study: Using Bacteria to Calm Your Mind (NCT02711800) | Nancy Zucker | 2016-11-08 |
| Impact of Periodontal Therapy on Patients With Diabetes (NCT04830969) | State University of New York at Buffalo | 2016-11-08 |
| Combination Nicotine Patch / Lorcaserin for Smoking Cessation (NCT02906644) | Duke University | 2016-11-08 |
| A Clinical Study of IRL790 in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia (NCT03531060) | Integrative Research Laboratories AB | 2016-11-08 |
| Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT02823574) | Bristol-Myers Squibb | 2016-11-08 |
| The UTHealth Ketamine Project (NCT02882711) | The University of Texas Health Science Center, Houston | 2016-11-07 |
| Gemcitabine and Nab-Paclitaxel vs Gemcitabine, Nab-Paclitaxel, Durvalumab and Tremelimumab as 1st Line Therapy in Metastatic Pancreatic Adenocarcinoma (NCT02879318) | Canadian Cancer Trials Group | 2016-11-07 |
| TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1-3A Follicular Lymphoma (NCT02927964) | Robert Lowsky | 2016-11-07 |
| Transverse Abdominis Plane Block for Anterior Approach Spine Surgery (NCT02884440) | Rennes University Hospital | 2016-11-07 |
| Brentuximab Vedotin in Chinese Participants With Relapsed/Refractory CD30-Positive Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL) (NCT02939014) | Takeda | 2016-11-07 |
| Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer (NCT02954991) | Mirati Therapeutics Inc. | 2016-11-07 |
| H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses (NCT02921997) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-11-07 |
| Auranofin for Giardia Protozoa (NCT02736968) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-11-06 |
| An Innovative Virtually Supervised Exercise for Dialysis Patients (NCT03076528) | Baylor College of Medicine | 2016-11-06 |
| Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE) (NCT02970305) | ACADIA Pharmaceuticals Inc. | 2016-11-04 |
| Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation (NCT02741856) | Lisette Nixon | 2016-11-04 |
| Physiologic Effects of Steroids in Cardiac Arrest (NCT02790788) | University of Athens | 2016-11-04 |
| Pembrolizumab and Imatinib in Patients With Locally Advanced/Metastatic Melanoma With c-KIT Mutation/Amplification (NCT02812693) | Joanne Jeter | 2016-11-04 |
| Effect of Andecaliximab on FEV1 in Adults With Cystic Fibrosis (NCT02759562) | Gilead Sciences | 2016-11-04 |
| A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Preterm Infants. (NCT02878330) | MedImmune LLC | 2016-11-03 |
| Safety, Tolerability and Pharmacokinetics of Oral Doses of RP3128 of Rhizen Pharmaceuticals (NCT02958982) | Rhizen Pharmaceuticals SA | 2016-11-03 |
| Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer (NCT02954536) | Memorial Sloan Kettering Cancer Center | 2016-11-03 |
| An Extension Protocol for Subjects Who Successfully Completed PRO140_CD02 or PRO140_CD02_Open Label Study (NCT02990858) | CytoDyn, Inc. | 2016-11-03 |
| Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC (NCT02593175) | M.D. Anderson Cancer Center | 2016-11-03 |
| Safety and Efficacy of CD10367 in Psoriasis Vulgaris (NCT03025282) | Galderma R&D | 2016-11-03 |
| 18FluoroLDOPA PET Imaging for the Detection and Localization of Focal Congenital Hyperinsulinism (NCT04205604) | Miguel Pampaloni | 2016-11-03 |
| Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week, Double-blind Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Failure (NCT02678312) | Novartis Pharmaceuticals | 2016-11-03 |
| Use of Oxygen in Heart Failure With Preserved Ejection Fraction (NCT02949531) | Hull University Teaching Hospitals NHS Trust | 2016-11-03 |
| 99mTc-rhAnnexin V-128 Imaging and Cardiotoxicity in Patients With Early Breast Cancer (NCT02677714) | Advanced Accelerator Applications | 2016-11-02 |
| Study of Magrolimab (Hu5F9-G4) in Combination With Cetuximab in Participants With Solid Tumors and Advanced Colorectal Cancer (NCT02953782) | Gilead Sciences | 2016-11-02 |
| LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis (NCT02205762) | North American Consortium for Histiocytosis | 2016-11-02 |
| Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed (NCT02935361) | University of Southern California | 2016-11-02 |
| High-dose Icotinib Treatment Beyond Progression in EGFR Mutant NSCLC (NCT02960607) | Chinese Academy of Medical Sciences | 2016-11-01 |
| Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis (NCT02949388) | Innovation Pharmaceuticals, Inc. | 2016-11-01 |
| Dinoprostone Vaginal Insert Versus Double Balloon Catheter for Preinduction Cervical Ripening (NCT03016442) | Kanuni Sultan Suleyman Training and Research Hospital | 2016-11-01 |
| Effect of SNF472 on Progression of Cardiovascular Calcification in End-Stage-Renal-Disease (ESRD) Patients on Hemodialysis (HD) (NCT02966028) | Sanifit Therapeutics S. A. | 2016-11-01 |
| To Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients With Conjunctivochalasis (NCT02810119) | Ocuwize LTD | 2016-11-01 |
| Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis (NCT02319616) | University of California, Davis | 2016-11-01 |
| Pharmacokinetic Study of Propylene Glycol-Free Melphalan HCl for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation (NCT02669615) | Medical College of Wisconsin | 2016-11-01 |
| Deciphering the Role of Oxytocin in Motivation: an fMRI Study. Part II (NCT02652195) | University of Utah | 2016-11-01 |
| tDCS Versus tsDCS for Endometriosis-related Chronic Pelvic Pain Treatment (NCT02958423) | Jean Schoenen | 2016-11-01 |
| Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury (NCT02975271) | Vyne Therapeutics Inc. | 2016-11-01 |
| Effect of PROGRESSive Training and Teststerone in Older Frail Men (NCT02873559) | University Hospital, Gentofte, Copenhagen | 2016-11-01 |
| CART-19 Cells For MRD Positive CD19+ ALL (NCT03027739) | Fujian Medical University | 2016-11-01 |
| Apatinib Mesylate Combined With Pemetrexed in the Treatment of Pretreated Advanced Non-squamous Non-small Cell Lung Cancer (NCT02974933) | Wuling Ou | 2016-11-01 |
| Anti-PD-1 Alone or Combined With Autologous Cell Therapy in Advanced NSCLC (NCT03360630) | Capital Medical University | 2016-11-01 |
| Study to Evaluate the Safety and Efficacy of PEER Interactive to Inform Medication Prescription for Subjects With a Primary Diagnosis of Depression (NCT02988076) | MYnd Analytics | 2016-11-01 |
| A Study of Tarceva vs. Avastin+Tarceva for Advanced NSCLC With EGFR m(+) (NCT03126799) | National Cancer Center, Korea | 2016-11-01 |
| Collagen Membrane Combined With HUC-MSCs Transplantation in Patients With Nasal Septum Perforation (NCT02947191) | Chinese Academy of Sciences | 2016-11-01 |
| (-)- Epicatechin Becker Muscular Dystrophy (NCT03236662) | Craig McDonald, MD | 2016-11-01 |
| Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas (NCT02763254) | Cell Medica Ltd | 2016-11-01 |
| Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy (NCT02953184) | Jilin University | 2016-11-01 |
| Study of VF001-DP in Patients With Chronic Venous Leg Ulcers (NCT02973893) | Factor Therapeutics Ltd. | 2016-11-01 |
| Ataluren for Nonsense Mutation in CDKL5 and Dravet Syndrome (NCT02758626) | NYU Langone Health | 2016-11-01 |
| Sitravatinib in Advanced Liposarcoma and Other Soft Tissue Sarcomas (NCT02978859) | Columbia University | 2016-11-01 |
| Clinical Research of TCM on Pelvic Inflammatory Disease Sequelae (NCT02972151) | Shanghai University of Traditional Chinese Medicine | 2016-11-01 |
| T-cells Expressing Anti-CD19 CAR in Pediatric and Young Adults With B-cell Malignancies (NCT02772198) | Sheba Medical Center | 2016-11-01 |
| Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty (NCT02982915) | Longeveron Inc. | 2016-11-01 |
| Study of Testosterone vs Placebo in Testicular Cancer Survivors (NCT02991209) | Mikkel Bandak | 2016-11-01 |
| Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinoma Patients (NCT02923557) | Peking University First Hospital | 2016-11-01 |
| Study to Evaluate Safety and Preliminary Efficacy of Tafasitamab With Idelalisib or Venetoclax in R/R CLL/SLL Patients Pretreated With BTKi (NCT02639910) | MorphoSys AG | 2016-11-01 |
| Spinal Versus Caudal Analgesia After Pediatric Infra-umbilical Surgery (NCT02988700) | Assiut University | 2016-11-01 |
| Early Simplified: A Trial to Compare the Efficacy of Standard of Care Combination Antiretroviral Therapy With a Simplified Dolutegravir Monotherapy in Patients With a Primary HIV-1 Infection (NCT02551523) | University of Zurich | 2016-11-01 |
| Trail Evaluating Particle Therapy With or Without Apatinib for H&N Adenoid Cystic Carcinoma (NCT02942693) | Shanghai Proton and Heavy Ion Center | 2016-11-01 |
| Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma (NCT02974647) | Memorial Sloan Kettering Cancer Center | 2016-11-01 |
| Phase II Trial to Assess FOLFIRI+Aflibercept Efficacy in Patients With Oxaliplatin-pretreated Metastatic Colorectal Cancer With or Without ACE Polymorphisms (NCT02970916) | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | 2016-11-01 |
| Study of Safety and Efficacy of Durvalumab in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer Patients (NCT02628132) | King Faisal Specialist Hospital & Research Center | 2016-11-01 |
| Safety, Reactogenicity, Immunogenicity, Efficacy of Influenza Vaccines Grippol® Quadri and Grippol® Plus in Volunteers (NCT03849560) | NPO Petrovax | 2016-11-01 |
| Combinating Fingolimod With Alteplase Bridging With Mechanical Thrombectomy in Acute Ischemic Stroke (NCT02956200) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2016-11-01 |
| Immune Checkpoint Inhibition in Combination With Radiation Therapy in Pancreatic Cancer or Biliary Tract Cancer Patients (NCT02866383) | Herlev Hospital | 2016-11-01 |
| Pharmacokinetics of Advantage Anti-Caries Varnish (NCT04183231) | Advantage Silver Dental Arrest, LLC | 2016-11-01 |
| A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma (NCT02770378) | University of Ulm | 2016-11-01 |
| CardiAQ-Edwards™ Transcatheter Mitral Valve Replacement (TMVR) Study (NCT02722551) | Edwards Lifesciences | 2016-11-01 |
| Study of Baricitinib, a JAK1/2 Inhibitor, in Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation (NCT02759731) | National Cancer Institute (NCI) | 2016-11-01 |
| The Effect Effect of Empagliflozin on Oxidative Stress in Patients With Type 2 Diabetes (NCT02890745) | Henrik Enghusen Poulsen | 2016-11-01 |
| Durvalumab, an Anti-PDLI Antibody, and Tremelimumab, an Anti-CTLA4 Antibody, and Chemoradiation Before Surgery for Esophageal Cancer (NCT02962063) | Memorial Sloan Kettering Cancer Center | 2016-11-01 |
| Erythropoietin to Prevent Unnecessary Transfusions In Patients With Cyanotic CHD - A Prospective Control Trial (NCT02564796) | University of California, San Diego | 2016-11-01 |
| A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins (NCT02634151) | NeuroBo Pharmaceuticals Inc. | 2016-11-01 |
| Pemirolast in Allergen Challenge (PEMAG) (NCT03119714) | Karolinska University Hospital | 2016-11-01 |
| Gemcitabine and Capecitabine With or Without T-ChOS as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (NCT02767752) | Herlev Hospital | 2016-11-01 |
| Effect of DLBS1033 After Primary PCI in Patients With STE-ACS (NCT02976701) | Dexa Medica Group | 2016-11-01 |
| Vinorelbine for Recurrent ACLC (NCT03397953) | Children's Cancer Group, China | 2016-11-01 |
| Testing Sunitinib as Potentially Targeted Treatment in Cancers With cKIT Genetic Changes (MATCH - Subprotocol V) (NCT06390826) | National Cancer Institute (NCI) | 2016-11-01 |
| Ultrasound Guided TAP Block for Postoperative Analgesia After Abdominal Surgery. (NCT02976597) | Assiut University | 2016-11-01 |
| Cetuximab Monotherapy Maintenance Treatment in mCRC (NCT02978313) | Ruijin Hospital | 2016-11-01 |
| SBRT in Multi-metastatic NSCLC Patients Which Are Pan-negative for Driver Mutations (NCT02940990) | Shanghai Chest Hospital | 2016-11-01 |
| Prevention of S. Aureus Pneumonia Study in Mechanically Ventilated Subjects Who Are Heavily Colonized With S. Aureus. (NCT02940626) | Arsanis, Inc. | 2016-11-01 |
| Chidamide for Advanced Cephalic and Cervical Adenocystic Carcinoma: Evaluation of Efficiency and Safety (NCT02883374) | Dong mei | 2016-11-01 |
| A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma (NCT02754362) | NYU Langone Health | 2016-11-01 |
| Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative (NCT03758287) | Sunshine Lake Pharma Co., Ltd. | 2016-11-01 |
| Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest (NCT02989168) | Global Blood Therapeutics | 2016-11-01 |
| TB Host Directed Therapy (NCT02968927) | The Aurum Institute NPC | 2016-11-01 |
| Sertraline in Addition to Standard of Care Treatment for Coccidioidomycosis (NCT02908334) | University of California, San Francisco | 2016-11-01 |
| Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel (NCT02925923) | University of Alabama at Birmingham | 2016-11-01 |